Oppenheimer's Colin Rusch on why he's neutral on Tesla
Colin Rusch, Oppenheimer senior research analyst, joins 'Squawk Box' to discuss Tesla's stock performance, the company's ...
Oppenheimer lifts Compass stock target to $12 on upbeat outlook
Oppenheimer's analyst Jason Helfstein increased the price target for Compass Inc. (NYSE:COMP) shares from $9.50 to $12.00, ...
Jewish Telegraphic Agency4d
The Jewish story behind ‘Oppenheimer,’ explained
(JTA) — Friday is not just “Barbie” release day — moviegoers are also planning to fill theaters across the United States to see Christopher Nolan’s “Oppenheimer” biopic. Many hope it ...
Another Oppenheimer actor is reuniting with Christopher Nolan for his next movie as filming begins next month
Benny Safdie is the latest actor to join the cast of The Odyssey, the next movie from Christopher Nolan, according to The Hollywood Reporter.
Oppenheimer: Solid Topline Performance And Multiple, But Comp Expense Caps Profit Growth
AUM and trading activity drives Oppenheimer's wealth management business. Read why we remain bullish on OPY stock.
Oppenheimer Keeps Their Buy Rating on Gilead Sciences (GILD)
In a report released today, Matthew Biegler from Oppenheimer reiterated a Buy rating on Gilead Sciences (GILD – Research Report), with a price ...
International Business Machines (NYSE:IBM) Earns Outperform Rating from Analysts at Oppenheimer
Oppenheimer assumed coverage on shares of International Business Machines (NYSE:IBM – Free Report) in a research note issued to investors on Tuesday morning, Marketbeat Ratings reports. The firm ...